{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:18:43Z","timestamp":1790914723382,"version":"4.1.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n \n Patients with cancer face an increased risk of\n Clostridioides difficile<\/jats:italic>\n infection (CDI) due to several factors, including chemotherapy and repeated health care exposures. However, recent national-level data characterizing the prevalence of CDI, associated clinical outcomes, and resource utilization in this population remain limited.\n <\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To characterize the hospitalization-level prevalence, clinical outcomes, and health care resource utilization associated with CDI among hospitalized patients with cancer in the US.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n \n This cross-sectional study used data from the National Inpatient Sample, a nationally representative database, to identify hospitalizations among adults with a diagnosis of cancer between January 1, 2016, and December 31, 2022. Hospitalizations with CDI were identified using\n International Statistical Classification of Diseases and Related Health Problems, Tenth Revision<\/jats:italic>\n codes. Data were analyzed from May to June 2025.\n <\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Presence of CDI as a primary or secondary diagnosis during the index hospitalization.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was in-hospital, all-cause mortality. Secondary outcomes included need for kidney replacement therapy, mechanical ventilation, vasopressor support, and colonoscopy. Multivariable logistic regression was used to adjust for demographics, comorbidities, cancer type, and hospital characteristics.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 32\u202f083\u202f671 cancer-related hospitalizations (overall study population mean [SD] patient age, 69.4 [13.9] years; 16\u202f050\u202f025 [50.0%] male), 450\u202f360 (1.4%) involved a diagnosis of CDI. Compared with hospitalizations without CDI, those with CDI involved older patients, a higher proportion of women, and higher prevalence of hematologic cancers, cirrhosis, solid organ transplant, bone marrow transplant, chronic kidney disease, and inflammatory bowel disease. Patients with CDI infection had higher in-hospital mortality (7.3% vs 4.5%; adjusted odds ratio [aOR], 1.62; 95% CI, 1.58-1.67) and greater use of critical care interventions. CDI was associated with higher rates of critical care interventions, including kidey replacement therapy (44.3 vs 20.4 per 1000 hospitalizations; aOR, 2.00; 95% CI, 1.92-2.08;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), mechanical ventilation (68.1 vs 35.6 per 1000 hospitalizations; aOR, 1.89; 95% CI, 1.84-1.95;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and vasopressor use (25.6 vs 11.5 per 1000 hospitalizations; aOR, 2.11; 95% CI, 2.00-2.24;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Mortality among patients with CDI varied geographically, ranging from 6.4% (95% CI, 6.2%-6.5%) in the Midwest to 8.5% (95% CI, 8.3%-8.7%) in the Northeast.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of US oncologic hospitalizations, CDI occurred in 1 in 70 cancer-related hospitalizations and was associated with significantly increased mortality and resource utilization. These findings underscore the need for targeted prevention and early intervention strategies in this vulnerable population.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.2103","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:30:37Z","timestamp":1774452637000},"page":"e262103","source":"Crossref","is-referenced-by-count":3,"title":["Clostridioides difficile<\/i>\n Infection Among Hospitalized Patients With Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Giovanni A.","family":"Roldan","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Goble","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Davie","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Campoverde","sequence":"additional","affiliation":[{"name":"Division of Hematology- Oncology, University of Texas, MD Anderson, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Mendoza","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne M.","family":"Moutsoglou","sequence":"additional","affiliation":[{"name":"Gastroenterology Section, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota"},{"name":"Department of Medicine, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"9","key":"zoi260095r1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States.","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"zoi260095r2","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals.","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi260095r3","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/antibiotics12121693","article-title":"Evaluating healthcare-associated infections in public hospitals: a cross-sectional study.","volume":"12","author":"Iancu","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"zoi260095r4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260095r5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.idc.2014.11.003","article-title":"The morbidity, mortality, and costs associated with Clostridium difficile infection.","volume":"29","author":"Kwon","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"zoi260095r6","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00520-017-3606-y","article-title":"Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.","volume":"25","author":"Hebbard","year":"2017","journal-title":"Support Care Cancer"},{"key":"zoi260095r7","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2018.1533673","author":"Abughanimeh","year":"2018","journal-title":"Hosp Pract (1995)"},{"issue":"1","key":"zoi260095r8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/cid\/ciz169","article-title":"Association between antibiotic use and hospital-onset Clostridioides difficile infection in US acute care hospitals, 2006-2012: an ecologic analysis.","volume":"70","author":"Kazakova","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260095r9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/clinids\/17.1.109","article-title":"Clostridium difficile infection associated with antineoplastic chemotherapy: a review.","volume":"17","author":"Anand","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi260095r10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1086\/322616","article-title":"Clostridium difficile infection in patients with neutropenia.","volume":"33","author":"Gorschl\u00fcter","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"11","key":"zoi260095r11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/668023","article-title":"Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report.","volume":"33","author":"Kamboj","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"zoi260095r12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.6004\/jnccn.2017.0046","article-title":"Trends in the incidence and outcomes of hospitalized cancer patients with Clostridium difficile infection: a nationwide analysis.","volume":"15","author":"Gupta","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"zoi260095r13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12879-017-2553-z","article-title":"Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals.","volume":"17","author":"Delgado","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"7","key":"zoi260095r14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1017\/ice.2015.54","article-title":"Outcomes of Clostridium difficile infection in hospitalized leukemia patients: a nationwide analysis.","volume":"36","author":"Luo","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"zoi260095r15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.20524\/aog.2022.0722","article-title":"Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors.","volume":"35","author":"Vasavada","year":"2022","journal-title":"Ann Gastroenterol"},{"issue":"7","key":"zoi260095r16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/INF.0b013e31820970d1","article-title":"Clostridium difficile infection among children with cancer.","volume":"30","author":"Tai","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"20","key":"zoi260095r18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1001\/jama.2017.17653","article-title":"Adherence to methodological standards in research using the national inpatient sample.","volume":"318","author":"Khera","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"zoi260095r19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.5306\/wjco.v15.i8.1048","article-title":"Prevalence of malignant neoplasms in celiac disease patients\u2014a nationwide United States population-based study.","volume":"15","author":"Haider","year":"2024","journal-title":"World J Clin Oncol"},{"issue":"1","key":"zoi260095r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.17597","article-title":"Incidence and outcomes associated with Clostridium difficile infections: a systematic review and meta-analysis.","volume":"3","author":"Marra","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"14","key":"zoi260095r21","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes.","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"zoi260095r22","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s10096-018-3341-4","article-title":"Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study.","volume":"37","author":"Larrainzar-Coghen","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"zoi260095r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157839","article-title":"Clostridium difficile infections amongst patients with haematological malignancies: a data linkage study.","author":"Selvey","journal-title":"PLoS One"},{"issue":"6","key":"zoi260095r24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s12185-014-1577-z","article-title":"Incidence and outcomes of Clostridium difficile-associated disease in hematopoietic cell transplant recipients.","volume":"99","author":"Guddati","year":"2014","journal-title":"Int J Hematol"},{"issue":"5","key":"zoi260095r25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ajic.2014.11.018","article-title":"Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010.","volume":"43","author":"Argamany","year":"2015","journal-title":"Am J Infect Control"},{"issue":"11","key":"zoi260095r26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/14787210.2016.1234376","article-title":"The epidemiology of Clostridium difficile infection in patients with cancer.","volume":"14","author":"Hebbard","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"zoi260095r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107785","article-title":"Clostridioides difficile infection and recurrence in cancer patients (CIRCA): a multicentre, international study.","volume":"153","author":"Puerta-Alcalde","year":"2025","journal-title":"Int J Infect Dis"},{"issue":"10","key":"zoi260095r28","doi-asserted-by":"publisher","first-page":"e776","DOI":"10.1016\/S2352-3026(22)00223-X","article-title":"Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice.","volume":"9","author":"Malard","year":"2022","journal-title":"Lancet Haematol"},{"issue":"21","key":"zoi260095r29","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.7150\/jca.59251","article-title":"Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients.","volume":"12","author":"Ali","year":"2021","journal-title":"J Cancer"},{"issue":"3","key":"zoi260095r30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jso.27923","article-title":"Impact of Clostridium difficile infection versus colonization on postoperative outcomes after oncological colorectal surgery: an observational single-center study with propensity score analysis.","volume":"131","author":"Ong","year":"2025","journal-title":"J Surg Oncol"},{"key":"zoi260095r17","unstructured":"HCUP-US NIS Overview. HCUP databases. February 2025. Accessed February 11, 2026. https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp#about"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846943\/roldan_2026_oi_260095_1773848834.60184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:30:40Z","timestamp":1774452640000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.2103","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}